Tag Archives: Antiviral

Hepatitis C infection – the coming revolution

Special Guest post from Dr Joshua Davis, Senior Staff Specialist Infectious Diseases: We are on the cusp of a revolution in the way we treat Hepatitis C Virus (HCV) infection. HCV matters, as it is common (about 1.5% of Australian adults are infected), and 20-30% of those infected end up with cirrhosis or liver cancer […]